Tuesday Poster Session
Category: Colon

Niketh Chopra, DO
Henry Ford Warren
Warren, MI
An 83 year-old female presented to the emergency department with acute onset of generalized weakness in the setting of decreased appetite and persistent diarrhea for several weeks after starting pirtobrutinib. The patient was first diagnosed with mediastinal MCL in 2005 and completed six cycles of rituximab with fludarabine in 2006. A follow-up PET scan showed no recurrence and screening colonoscopy in 2011 was without abnormalities. MCL subsequently relapsed in the mediastinum in 2021. The patient was started on zunibrutinib with complete response and had a negative PET scan in 2022. Zunibrutinib was continued until the patient developed a community acquired pneumonia prompting transition to pirtobrutinib. Shortly after transition and one week prior to presentation, an out-patient PET Scan showed increased uptake in the distal sigmoid colon, mediastinal lymph nodes, and lungs bilaterally.
On arrival, the patient was hemodynamically stable, but hemoglobin was 6.8 gm/dL (down from baseline of 10). After resuscitation, colonoscopy was completed and a polypoid lesion in the sigmoid colon was identified, as well as, a lipomatous ileocecal valve with AVMs and friable tissue. Biopsies were taken from each site and hemospray was applied for hemostasis. Pathology was consistent with MCL in both locations. GI bleeding resolved and the patient was discharged home after treatment for concurrent pneumonia. The patient returned several weeks later with profound sepsis secondary to pneumonia and palliative measures were pursued.

